← Back to Conditions

Pneumococcal pneumonia

disorder
SNOMED 233607000CUI C0155862

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Gemifloxacin

substance

Gemifloxacin mesylate

substance

Clinical Trials

8
Total Trials
0
Recruiting
2
With Results

Recent Trials

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

NCT00744263Phase 4Completed84,496 enrolled

Evaluation of PCV Schedules in a Naive Population in Vietnam

NCT02961231Phase 4Completed18,652 enrolled

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

NCT04559204Phase 4Completed1,224 enrolled

Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4

NCT04790851Phase 4Completed1,133 enrolled

The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

NCT02592486Phase 4Completed162 enrolled
View all 8 trials on ClinicalTrials.gov

Related Conditions

Pneumococcal lobar pneumonia(child)
Pneumococcal pneumonia with acquired immunodeficiency syndrome(child)
Bronchopneumonia caused by Streptococcus pneumoniae(child)
Streptococcal pneumonia(parent)
Pneumococcal infectious disease(parent)
Pneumonia caused by aerobic bacteria(parent)

Quick Facts

SNOMED CT
233607000
UMLS CUI
C0155862
Fully Specified Name
Pneumococcal pneumonia (disorder)
Specialists
0
Diagnostic Biomarkers
0
Known Treatments
2
Clinical Trials
8
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.